AFFINITY-DUCHENNE Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for AFFINITY-DUCHENNE with the United States Patent and Trademark Office. The USPTO has given the AFFINITY-DUCHENNE trademark a serial number of 97125450. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by REGENXBIO Inc.. The AFFINITY-DUCHENNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others
affinity-duchenne

General Information

Serial Number97125450
Word MarkAFFINITY-DUCHENNE
Filing DateMonday, November 15, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of clinical trials; Medical and scientific research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Monday, August 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023SOU EXTENSION 1 FILED
Wednesday, May 24, 2023SOU EXTENSION 1 GRANTED
Friday, May 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

duchenne affinity trials clinical research medical scientific conducting others namely field information